作为细胞免疫的纳米级控制器重新编程外体
Qinqin Cheng1, Xiaojing Shi1, Menglu Han1
1Department of Pharmacology and Pharmaceutical Sciences, School of Pharmacy , University of Southern California , Los Angeles , California 90089 , United States.
Journal of the American Chemical Society
|November 20, 2018
概括
研究人员设计出外基因组以向癌细胞, 引导免疫T细胞有效杀死癌细胞. 这种新奇的纳米医学方法,即合成多价值抗体重定位外体 (SMART-Exos),显示出无细胞癌症免疫治疗的前景.
科学领域:
- 纳米医学
- 免疫学
- 癌症学
背景情况:
- 体是具有治疗潜力的天然囊泡.
- 目前的纳米医学依赖于有效的治疗方法.
- 细胞免疫力,特别是细胞毒性T细胞,对于杀死癌症至关重要.
研究的目的:
- 探索内源性外体作为细胞免疫的控制者.
- 将细胞毒性T细胞转向和激活到癌细胞.
- 开发一种新的癌症免疫疗法方法,
主要方法:
- 在外体表面显示两种不同的抗体.
- 创建合成多价抗体重定位外体 (SMART-Exos).
- 使用针对T细胞CD3和癌细胞相关的表皮生长因子受体 (EGFR) 的抗体.
主要成果:
- SMART-Exos诱导了T细胞和表达EGFR的癌细胞的交叉链接.
- 在体外和体内表现出强大的抗瘤免疫力.
- 验证了用于癌症免疫治疗的工程外体的概念.
结论:
- 工程外体可以作为细胞免疫的人工控制器.
- SMART-Exos为癌症免疫治疗提供了一种全新的多功能方法.
- 这项研究为一种新的无细胞癌症疗法铺平了道路.
相关概念视频
Combinatorial Gene Control
9.7K
Combinatorial gene control is the synergistic action of several transcriptional factors to regulate the expression of a single gene. The absence of one or more of these factors may lead to a significant difference in the level of gene expression or repression.
The expression of more than 30,000 genes is controlled by approximately 2000-3000 transcription factors. This is possible because a single transcription factor can recognize more than one regulatory sequence. The specificity in gene...
The expression of more than 30,000 genes is controlled by approximately 2000-3000 transcription factors. This is possible because a single transcription factor can recognize more than one regulatory sequence. The specificity in gene...
9.7K
What is the Immune System?
128.0K
Overview
128.0K
Overview of Exosomes
3.7K
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
3.7K
Humoral Immune Responses
83.9K
Overview
83.9K
Introduction to Nuclear Reprogramming
2.3K
Nuclear reprogramming is the process of switching gene expression of one cell type to that of another cell type, usually from a differentiated cell state to an undifferentiated cell state. Differentiation occurs during processes such as development and morphogenesis, tissue regeneration, and malignancy. Cells can also be artificially induced to reprogram their gene expression by techniques such as nuclear transfer, induced pluripotency, and cell fusion. Such techniques have many applications in...
2.3K
Methods of Nuclear Reprogramming
2.1K
Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for...
2.1K


